Ernst & Young / M. A. Fischl D. D. / Oncology Group / R. A. Harte A. S. / J. Hillman-Jackson A. S. / S. Hartman A. E. / NCATS / L. J. Picker A. S. / H. / The New York Times / Z. / /
Continent
America / Europe / /
Country
Canada / United States / /
Currency
USD / / /
Event
FDA Phase / Reorganization / /
Facility
Baylor College of Medicine Human Genome Sequencing Center / University Genome Sequencing Center / Broad Institute / National Human Genome Research Institute / National Institute of Allergy / National Cancer Institute / AIDS-related complex / S. Dike / Children’s Hospital Oakland Research Institute / /
IndustryTerm
bio technology / pharmaceutical industry / clinical network / phase zero technologies / molecular technologies / molecu lar imaging / translational solutions / manufacturing / venture capital / clinical applications / cellular networks / biotechnology / treatment of heart disease / treatment of other diseases / power ful new tools / pharmaceutical / chemical genomics / treatment of many diseases / honest broker / actual products / real-world applications / therapeutic and experimental chemical entities / candidate products / Therapeutics for Rare and Neglected Diseases / /
MedicalCondition
HIV / multiple myeloma / Multiple sclerosis / human diseases / Psoriasis / coronary heart disease / breast cancer / rare and common diseases / adaptive breast cancer / morn ing sickness / cancer / complex diseases / diabetes / Gaucher’s disease / Marfan syndrome / diseases / tious Diseases / AIDS / Mendelian disorders / pre vent disease / heart disease / common diseases / AIDS-related complex / disease / Neglected Diseases / Hyperlipidemia / rare and neglected diseases / rarer diseases / Marfan’s syndrome / /
U.S. Department of Health and Human Services / National Human Genome Research Institute / Defense Advanced Research Projects Agency / National Institute of Allergy and Infec / National Center / Baylor College of Medicine / National Center for Advancing Translational Sciences / FDA / National Cancer Institute / Ucla / Medicine Human Genome Sequencing Center / National Institute of Health / Broad Institute / NIH Common Fund / Congress / U.S. Food and Drug Administration / D. Church / Washington University Genome Sequencing Center / Children’s Hospital Oakland Research Institute / Environmental Protection Agency / Genomewide association / /
Person
T. A. Richmond / Nat / D. T. Durack / Y. Ruan / V / T. H. Mosley Jr. / R. Stuart / N. Lopez-Bigas / J. P. Habashi / S. Van Calcar / X. Ma / J. R. Idol / V / A. Karpas / J. D. Lieb / J. B. Brown / L. J. Esserman / F. Yao / V / A. Ameur / Y. Li / J. C. Parke / Jr / N. P. Carter / P. J. Boyle / J. Dekker / N. Patel / Silver Spring / /
Position
broker / Director / National Institutes of Health / tissue-engineered organoids representative / Governor / I-SPY / director / T. D. / Singer / King / D. P. Judge / Cao / /
Reengineering Translational Science: The Time Is Right